Combined therapy
A compound, tissue-damaging technology, applied in the field of combination therapy, can solve problems such as delayed tissue sodium overload
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Method used
Examples
Embodiment Construction
[0010] The present invention provides a method of reducing tissue damage (e.g., substantially preventing tissue damage and / or producing tissue protection) due to ischemia comprising, administering to a mammal (e.g., human, male) in need of such reduction or female) administering a therapeutically effective amount of a type 1 sodium-hydrogen exchanger (NHE-1) inhibitor and selected from (a) a complement modulator, (b) a metabolic modulator, (c) an anti-apoptotic agent, (d) ) nitric oxide synthase-related substances and (e) selected from protein kinase C activators, endothelin-converting enzyme inhibitors, tissue-activated fibrinolysis inhibitors (TAFI), Na + / Ca +2 Combination of a second compound of an enzyme / protein modulator of an exchanger isoform-1 (NCX-1) inhibitor and a poly(ADP-ribose) synthetase (PARS / PARP) inhibitor, or a medicament containing the combination combination.
[0011] Preferred ischemic tissues that may be treated according to the method of the present ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com